231 related articles for article (PubMed ID: 33758258)
21. d-Enantiomeric RTHLVFFARK-NH
Liu W; Dong X; Sun Y
ACS Chem Neurosci; 2019 Mar; 10(3):1390-1401. PubMed ID: 30650306
[TBL] [Abstract][Full Text] [Related]
22. Identification of a Novel Multifunctional Ligand for Simultaneous Inhibition of Amyloid-Beta (Aβ
Asadbegi M; Shamloo A
ACS Chem Neurosci; 2019 Nov; 10(11):4619-4632. PubMed ID: 31566950
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect of human serum albumin on Cu-induced Aβ(40) aggregation and toxicity.
Lu N; Yang Q; Li J; Tian R; Peng YY
Eur J Pharmacol; 2015 Nov; 767():160-4. PubMed ID: 26463036
[TBL] [Abstract][Full Text] [Related]
24. Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease.
House E; Collingwood J; Khan A; Korchazkina O; Berthon G; Exley C
J Alzheimers Dis; 2004 Jun; 6(3):291-301. PubMed ID: 15201484
[TBL] [Abstract][Full Text] [Related]
25. Development of multifunctional heterocyclic Schiff base as a potential metal chelator: a comprehensive spectroscopic approach towards drug discovery.
Jadhao M; Das C; Rawat A; Kumar H; Joshi R; Maiti S; Ghosh SK
J Biol Inorg Chem; 2017 Jan; 22(1):47-59. PubMed ID: 27822620
[TBL] [Abstract][Full Text] [Related]
26. Design of nonapeptide LVFFARKHH: A bifunctional agent against Cu
Zhang H; Zhang C; Dong XY; Zheng J; Sun Y
J Mol Recognit; 2018 Jun; 31(6):e2697. PubMed ID: 29318655
[TBL] [Abstract][Full Text] [Related]
27. Screening a specific Zn(ii)-binding peptide for improving the cognitive decline of Alzheimer's disease in APP/PS1 transgenic mice by inhibiting Zn
Zhang X; Zhong M; Zhao P; Zhang X; Li Y; Wang X; Sun J; Lan W; Sun H; Wang Z; Gao H
Biomater Sci; 2019 Nov; 7(12):5197-5210. PubMed ID: 31588929
[TBL] [Abstract][Full Text] [Related]
28. Mercury and Alzheimer's Disease: Hg(II) Ions Display Specific Binding to the Amyloid-β Peptide and Hinder Its Fibrillization.
Wallin C; Friedemann M; Sholts SB; Noormägi A; Svantesson T; Jarvet J; Roos PM; Palumaa P; Gräslund A; Wärmländer SKTS
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31892131
[TBL] [Abstract][Full Text] [Related]
29. Alzheimer's beta-amyloid peptide: affinity for metal chelates.
Balakrishnan R; Parthasarathy R; Sulkowski E
J Pept Res; 1998 Feb; 51(2):91-5. PubMed ID: 9516042
[TBL] [Abstract][Full Text] [Related]
30. A Novel Cu(II)-Binding Peptide Identified by Phage Display Inhibits Cu
Zhang X; Zhang X; Zhong M; Zhao P; Guo C; Li Y; Xu H; Wang T; Gao H
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202166
[TBL] [Abstract][Full Text] [Related]
31. Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation.
Abelein A; Gräslund A; Danielsson J
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5407-12. PubMed ID: 25825723
[TBL] [Abstract][Full Text] [Related]
32. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators.
Tõugu V; Karafin A; Zovo K; Chung RS; Howells C; West AK; Palumaa P
J Neurochem; 2009 Sep; 110(6):1784-95. PubMed ID: 19619132
[TBL] [Abstract][Full Text] [Related]
33. Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents.
Du Z; Li M; Ren J; Qu X
Acc Chem Res; 2021 May; 54(9):2172-2184. PubMed ID: 33881820
[TBL] [Abstract][Full Text] [Related]
34. Conjugation of RTHLVFFARK to human lysozyme creates a potent multifunctional modulator for Cu
Li X; Wang W; Dong X; Sun Y
J Mater Chem B; 2020 Mar; 8(11):2256-2268. PubMed ID: 32100783
[TBL] [Abstract][Full Text] [Related]
35. Is interaction of amyloid β-peptides with metals involved in cognitive activity?
Tamano H; Takeda A
Metallomics; 2015 Aug; 7(8):1205-12. PubMed ID: 25959547
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Aβ peptide aggregation by ruthenium(II) polypyridyl complexes through copper chelation.
Peng YB; Tao C; Tan CP; Zhao P
J Inorg Biochem; 2021 Nov; 224():111591. PubMed ID: 34450410
[TBL] [Abstract][Full Text] [Related]
37. Residue-specific binding of Ni(II) ions influences the structure and aggregation of amyloid beta (Aβ) peptides.
Berntsson E; Vosough F; Svantesson T; Pansieri J; Iashchishyn IA; Ostojić L; Dong X; Paul S; Jarvet J; Roos PM; Barth A; Morozova-Roche LA; Gräslund A; Wärmländer SKTS
Sci Rep; 2023 Feb; 13(1):3341. PubMed ID: 36849796
[TBL] [Abstract][Full Text] [Related]
38. The S100B Alarmin Is a Dual-Function Chaperone Suppressing Amyloid-β Oligomerization through Combined Zinc Chelation and Inhibition of Protein Aggregation.
Cristóvão JS; Figueira AJ; Carapeto AP; Rodrigues MS; Cardoso I; Gomes CM
ACS Chem Neurosci; 2020 Sep; 11(17):2753-2760. PubMed ID: 32706972
[TBL] [Abstract][Full Text] [Related]
39. Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease.
Nam E; Derrick JS; Lee S; Kang J; Han J; Lee SJC; Chung SW; Lim MH
ACS Chem Neurosci; 2018 Nov; 9(11):2655-2666. PubMed ID: 29782798
[TBL] [Abstract][Full Text] [Related]
40. Calprotectin influences the aggregation of metal-free and metal-bound amyloid-β by direct interaction.
Lee HJ; Savelieff MG; Kang J; Brophy MB; Nakashige TG; Lee SJC; Nolan EM; Lim MH
Metallomics; 2018 Aug; 10(8):1116-1127. PubMed ID: 30046785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
